Strengthening Care in Collaboration With People With Lived Experience of Psychosis in Uganda
NCT ID: NCT05863572
Last Updated: 2025-06-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
132 participants
INTERVENTIONAL
2023-09-05
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
School-Based Mental Health Program Implementation in Uganda
NCT01857388
School-Based Mental Health Effectiveness Study
NCT04383327
Ensuring Quality in Psychological Support
NCT04704362
The Effect of Integrating CAMH Into PHC and Traditional Healers' Practice in Uganda: a Randomized Controlled Trial
NCT02552056
Journey of Life Psychosocial Support Program
NCT04817098
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objective 1 - To assess the feasibility and acceptability of the implementation strategy from the perspective of people with lived experience of psychosis, family members and primary and community care providers.
Objective 2 - To demonstrate proof-of-concept for the benefit of the implementation strategy for service users (i.e., patients with psychosis receiving primary care services) and their families, including changes in psychosis symptoms, quality of life, frequency of hospitalization and the potential impacts on family members.
Objective 3 - To evaluate changes in health systems outcomes in terms of primary care provider knowledge, attitudes, competency in psychosis diagnosis and management, accuracy of diagnosis and fidelity to treatment guidelines in actual care settings as well as trial procedures.
Objective 4: To evaluate costing, recruitment and retention, and data collection procedures and protocols to determine the optimal design for a future fully powered cluster Randomized Controlled Trial.
Objective 5: To establish and demonstrate ethics and safety in collaborating with service users.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment as usual
Training primary care workers in diagnosis and treatment; training community health workers in detection and referral.
Primary care health worker training
Training primary care workers to detect and treat psychosis.
Community Health Workers Training
training community health workers in detection and referral
Strengthening care in collaboration with people with lived experience of psychosis in Uganda
Trainings done in collaboration with people with lived experience of psychosis; as well as additional home visits conducted by people with lived experience of psychosis.
Primary care health worker training
Training primary care workers to detect and treat psychosis.
Community Health Workers Training
training community health workers in detection and referral
Home visits
home visits conducted by people with lived experience of psychosis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Primary care health worker training
Training primary care workers to detect and treat psychosis.
Community Health Workers Training
training community health workers in detection and referral
Home visits
home visits conducted by people with lived experience of psychosis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. At least 18 years of age
2. Confirmed diagnosis of a primary psychotic disorder (e.g., schizophrenia) by a psychiatrist or psychiatric clinical officer
3. Completion of the YouBelongHOME (YBH) program
4. Provision of informed consent,
5. Fluency in the local language (Luganda)
6. Good functioning with respect to performance of daily chores,engagement with family members, comprehension and community participation as assessed by the YBH team
7. A supportive family member.
2. Primary care providers:
1. Provides primary care in health facility of Kampala/Wakiso District
2. Selected by facility in-charge
3. Community health workers
1. Provides community based health service in health facility where primary care providers are trained (from Kampala/Wakiso district)
2. Selected by facility in-charge
4. Patients (Primary beneficiaries)
1. Persons diagnosed with psychosis at a primary health care facility in Kampala/Wakiso District; For this study, a diagnosis of psychosis will include the following diagnoses according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5):schizophrenia spectrum and other psychotic disorders \[brief psychotic disorder, schizophreniform disorder, schizoaffective disorder, schizophrenia, and organic psychosis (i.e., psychosis secondary to a medical condition such as HIV or an alcohol- or substance-use disorder)\];bipolar affective disorder and related disorders;
2. Ability of the patient or responsible surrogate to consent to study enrolment and procedures;
3. Persons eligible for outpatient management of psychosis
5. Family members a. Family member or caregiver of the patients above.
Exclusion Criteria
a. Inability to provide informed consent.
2. Primary care providers:
None
3. Community health workers:
None
4. Patients
1. Persons diagnosed with psychosis requiring inpatient management/services; and
2. Persons for whom consent for participation in the study cannot be obtained.
3. Patients found to be severely ill beyond the capacity of the health facility to treat.
5. Family members a. Family members who doesn't provide consent for participation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
YouBelong Uganda
UNKNOWN
Butabika National Referral Hospital
UNKNOWN
George Washington University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Brandon A Kohrt, MD, PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Brandon Kohrt, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
George Washington University
Byamah Mutamba, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
YouBelong Uganda
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
YouBelong Uganda
Kampala, , Uganda
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Mutamba BB, Rai S, Semakula L, Cappo D, Asher L, Gwaikolo W, Kohrt BA. Strengthening care in collaboration with people with lived experience of psychosis in Uganda (SCAPE-U): A protocol for a cluster randomized controlled feasibility trial. Pilot Feasibility Stud. 2025 Jul 21;11(1):103. doi: 10.1186/s40814-025-01684-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HS2327ES
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.